As we approach the end of another workweek, it’s time to start thinking about weekend plans. Our schedule includes tending to the Pharmalot grounds, spending time with our beloved mascots, and catching up on some much-needed rest. We’re also looking forward to hosting a listening party with a great playlist lined up. How about you? This is the perfect opportunity to enjoy the outdoors and start planning for the upcoming holidays. Maybe you’ll use this time to reflect on recent events and make some decisions about the future. Whatever you choose to do, make sure to stay safe and have a wonderful time. See you soon!
The U.S. Food and Drug Administration is considering banning oral phenylephrine from over-the-counter cold and cough medicines due to its lack of effectiveness. This ingredient is commonly found in popular products like Benadryl, Advil, and Tylenol. While phenylephrine is still used in nasal sprays, the FDA believes it is not effective when taken orally. Last year, a panel of experts unanimously agreed that oral phenylephrine does not work as a decongestant, leading to this proposed ban. Several companies, including Procter & Gamble and GSK, are facing lawsuits for allegedly misleading consumers about the benefits of cold medicines containing phenylephrine.
Eisai, a pharmaceutical company, has revised its sales projections for the Alzheimer’s drug Leqembi after experiencing slow uptake. Despite initial optimism, sales of the drug have only reached $107 million, with most of the revenue coming from the U.S. The company had to adjust its sales forecast for the year due to regulatory challenges in the EU and Australia, where approvals are unlikely due to concerns about the drug’s efficacy and side effects. Additionally, reimbursement decisions in England and Wales have not been favorable, further impacting the drug’s market potential.
Overall, these developments in the pharmaceutical industry highlight the importance of regulatory scrutiny and consumer protection. It’s crucial for companies to provide accurate information about their products and for regulatory agencies to ensure the safety and efficacy of medications available to the public. As we navigate these changes, it’s essential to stay informed and make decisions based on reliable information. Enjoy your weekend and stay tuned for more updates in the world of pharmaceuticals.
